BioNeutra Global Corp (BGA) - Net Assets
Based on the latest financial reports, BioNeutra Global Corp (BGA) has net assets worth CA$-8.23 Million CAD (≈ $-5.95 Million USD) as of September 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CA$13.57 Million ≈ $9.82 Million USD) and total liabilities (CA$21.81 Million ≈ $15.77 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of BioNeutra Global Corp to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CA$-8.23 Million |
| % of Total Assets | -60.64% |
| Annual Growth Rate | N/A |
| 5-Year Change | -230.33% |
| 10-Year Change | -158.23% |
| Growth Volatility | 187.09 |
BioNeutra Global Corp - Net Assets Trend (2013–2023)
This chart illustrates how BioNeutra Global Corp's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of BioNeutra Global Corp for the complete picture of this company's asset base.
Annual Net Assets for BioNeutra Global Corp (2013–2023)
The table below shows the annual net assets of BioNeutra Global Corp from 2013 to 2023. For live valuation and market cap data, see BGA market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | CA$-6.19 Million ≈ $-4.48 Million |
-64.92% |
| 2022-12-31 | CA$-3.76 Million ≈ $-2.72 Million |
-263.28% |
| 2021-12-31 | CA$-1.03 Million ≈ $-747.87K |
-247.50% |
| 2020-12-31 | CA$700.92K ≈ $507.03K |
-85.25% |
| 2019-12-31 | CA$4.75 Million ≈ $3.44 Million |
-73.68% |
| 2018-12-31 | CA$18.06 Million ≈ $13.06 Million |
+29.39% |
| 2017-12-31 | CA$13.96 Million ≈ $10.10 Million |
-11.57% |
| 2016-12-31 | CA$15.78 Million ≈ $11.42 Million |
+3.93% |
| 2015-12-31 | CA$15.19 Million ≈ $10.99 Million |
+42.76% |
| 2014-12-31 | CA$10.64 Million ≈ $7.70 Million |
+452.50% |
| 2013-12-31 | CA$1.93 Million ≈ $1.39 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BioNeutra Global Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1592.2% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CA$9.86 Million | % |
| Total Equity | CA$-6.19 Million | 100.00% |
BioNeutra Global Corp Competitors by Market Cap
The table below lists competitors of BioNeutra Global Corp ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mastrad
PA:ALMAS
|
$1.01 Million |
|
PHAXIAM Therapeutics S.A.
PA:PHXM
|
$1.01 Million |
|
Brave Bison Group PLC
LSE:BBSN
|
$1.01 Million |
|
Troubadour Resources Inc
V:TR
|
$1.01 Million |
|
Ten Lifestyle Group PLC
LSE:TENG
|
$1.01 Million |
|
Satis Group S.A.
WAR:STS
|
$1.01 Million |
|
Maven Income and Growth VCT 4 PLC
LSE:MAV4
|
$1.01 Million |
|
Ristia Bintang Mahkotasejati
JK:RBMS
|
$1.01 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BioNeutra Global Corp's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from -3,755,748 to -6,193,962, a change of -2,438,214.
- Net loss of 2,107,579 reduced equity.
- Other factors decreased equity by 330,635.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CA$-2.11 Million | -34.03% |
| Other Changes | CA$-330.63K | -5.34% |
| Total Change | CA$- | % |
Book Value vs Market Value Analysis
This analysis compares BioNeutra Global Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | CA$0.30 | CA$0.03 | x |
| 2018-12-31 | CA$0.39 | CA$0.03 | x |
| 2019-12-31 | CA$0.10 | CA$0.03 | x |
| 2020-12-31 | CA$0.02 | CA$0.03 | x |
| 2021-12-31 | CA$-0.02 | CA$0.03 | x |
| 2022-12-31 | CA$-0.08 | CA$0.03 | x |
| 2023-12-31 | CA$-0.13 | CA$0.03 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BioNeutra Global Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -18.52%
- • Asset Turnover: 0.72x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-62.77%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 35.26% | 8.96% | 1.23x | 3.21x | CA$486.31K |
| 2014 | 48.04% | 32.61% | 1.13x | 1.30x | CA$4.05 Million |
| 2015 | 1.18% | 1.12% | 0.60x | 1.76x | CA$-1.34 Million |
| 2016 | 6.84% | 4.15% | 0.71x | 2.32x | CA$-498.78K |
| 2017 | -8.32% | -3.61% | 1.04x | 2.22x | CA$-2.56 Million |
| 2018 | 17.18% | 8.23% | 0.94x | 2.21x | CA$1.30 Million |
| 2019 | -261.83% | -33.01% | 1.11x | 7.16x | CA$-12.92 Million |
| 2020 | -528.87% | -15.37% | 1.02x | 33.78x | CA$-3.78 Million |
| 2021 | 0.00% | -18.37% | 0.73x | 0.00x | CA$-2.73 Million |
| 2022 | 0.00% | -21.82% | 0.68x | 0.00x | CA$-2.55 Million |
| 2023 | 0.00% | -18.52% | 0.72x | 0.00x | CA$-1.49 Million |
Industry Comparison
This section compares BioNeutra Global Corp's net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $230,254,418
- Average return on equity (ROE) among peers: -118.65%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BioNeutra Global Corp (BGA) | CA$-8.23 Million | 35.26% | N/A | $1.01 Million |
| Astron Connect Inc (AST) | $3.15 Million | -85.83% | 0.13x | $656.93K |
| Else Nutrition Holdings Inc (BABY) | $-43.05K | 0.00% | 0.00x | $811.89K |
| Burcon NutraScience Corporation (BU) | $5.15 Million | -144.49% | 1.51x | $21.03 Million |
| Canyon Creek Food Company Ltd (CYF) | $-16.44 Million | 0.00% | 0.00x | $508.52K |
| High Liner Foods Incorporated (HLF) | $3.99 Million | -801.89% | 24.85x | $290.99 Million |
| Inter Rock Minerals Inc (IRO) | $1.22 Million | 61.37% | 12.97x | $17.45 Million |
| Jamieson Wellness Inc (JWEL) | $481.19 Million | 9.95% | 1.38x | $1.04 Billion |
| Lifeist Wellness Inc (LFST) | $55.78 Million | -113.25% | 0.21x | $1.10 Million |
| Maple Leaf Foods Inc. (MFI) | $1.54 Billion | 6.28% | 1.88x | $2.58 Billion |
About BioNeutra Global Corp
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, Europ… Read more